HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients—Gene Therapy for Pleural Malignancies

Read about a current clinical trial on gene therapy being conducted on patients with advanced cancer or malignant mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. This trial is currently only being conducted in Switzerland.

Gene Therapy for Pleural Malignancies

Purpose

This Phase I study will evaluate the safety of two doses of BG00001. Eligible subjects will have:

  • malignant pleural mesothelioma, or
  • pleural effusions who have progressed through at least one prior therapy or have refused therapy

BG00001 is given twice, on Day 1 and Day 15. BG00001 is given through a catheter in the pleural space.

Phase, Condition and Intervention

Phase I; Pleural Mesothelioma, Metastatic Pleural Effusions; Gene Transfer: BG00001 (adenoviral-mediated interferon-beta)

Study Type and Design

Interventional; Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety Study

Official Title:

A Phase I Clinical Trial of Repeated Dose Intrapleural Adenoviral-Mediated Interferon-Beta (BG00001, Ad.hIFN-ß for Pleural Malignancies

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

 

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


Mesothelioma
Latest News
Recent Developments
IN THIS SECTION
mesothelioma gene therapy measures
mesothelioma gene therapy criteria
Gene Therapy Contacts for Mesothelioma
Printed material for mesothelioma patients
Outcome measures for Mesothelioma materials
Objectives for mesothelioma materials
Mesothelioma printed materials outline
Mesothelioma: Printed Materials & Disease
Printed mesothelioma materials info contact

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

mesothelioma gene therapy measures Outcome measures for mesothelioma patients using gene therapy
Outcome measures of gene therapy for mesothelioma patients

Mesothelioma printed materials outline Outline for developing printed materials for mesothelioma patients
Read outline for creating printed materials for mesothelioma patients

Mesothelioma: Cancer Research American Assn. for Cancer Research awards doctor for mesothelioma work
Doctor's research work on mesothelioma cancer wins him a $100K grant